SEC Form 4 · accession 0001144204-17-046175
BRAINSTORM CELL THERAPEUTICS INC. · BCLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Irit Arbel
Director
Period of report
Aug 31, 2017
Accepted (ET)
Aug 31, 2017 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001137883
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 31, 2017 | P | 2,500 | $4.26 | A | 155,833 | D |
Table II — derivative securities
No Table II lines on this filing.